On Tuesday, November 2, the CDC approved the COVID-19 Pfizer vaccination for children ages 5 to 11 years. The approval means about 28 million children in the United States in this age group are eligible for the vaccine. NAESP would like to hear from its members to learn more about how the approval of the vaccine impacts schools and what additional supports might be necessary.
